Biotech stocks have pulled back and offer better risk to reward for investors, Direxion Daily S&P Biotech Bull 3x Shares ETF is a popular way to trade them. M&A is likely to drive prices for mid-cap ...
Exchange-traded funds aren’t slowing down. Firms launch new ETFs every day, assets continue to pour in, and investors and providers alike are starting to wade into previously uncharted waters. ETFs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results